Alteration of oxidative stress parameters in red blood cells of rats after chronic in Vivo treatment with cisplatin and selenium

Archives of Biological Sciences

Volumn 63, Issue 4, 2011, Pages 991-1000

  Marković, Snežana D ^a   Žižić, Jovana B ^a   Djačić, Dragana S ^a   Obradović, Ana D ^a   Ćurčić, Milena G ^a   Cvetković, Danijela M ^a   Dordević, Nataša Z ^a   Ognjanović, Branka I ^a   Stajn A S ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Antioxidative defense system; Cisplatin; Hematology; Oxidative stress; Selenium

Indexed keywords

EID: 84857981342     PISSN: 03544664     EISSN: None     Source Type: Journal    
DOI: 10.2298/ABS1104991M     Document Type: Article

References (44)

1. Arnelle, L. and J. Stamler (1996). Detection of hydroxylamine. In: Methods in Nitric Oxide Research (Eds. M. Feelisch, and J.S. Stamler), 541-552. Wiley, London.
2. Agarwal, R. and J.R. Behari (2007). Role of selenium in mercury intoxication in mice. Ind. Health 45, 388-395.
3. Antunes, L.M.G., Darin, J.D.C., and M.L.P. Bianchi (1999). Anticlastogenic effect of vitamin C on cisplatin in vivo. Genet. Mol. Biol. 22, 415-418.
4. Antunes, L.M.G., Araujo, M.C.P., Darin, J.D.C., and M.L.P. Bianchi (2000). Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells. Mutat. Res. 465, 131-137.
5. Auclair, C. and E. Voisin (1985). Nitroblue tetrazolium reduction. In: Handbook of Methods for Oxygen Radical Research (Ed. R.A. Greenwald). CRC Press, Inc.: Boa Raton.
6. Ayhanci, A., Gunes, S., Sahinturk, V., Appak, S., Uyar, R., Cengiz, M., Altuner, Y., and S. Yaman (2009). Seleno L-: Methionine Acts on Cyclophosphamide-Induced Kidney Toxicity. Biol. Trace Elem. Res. 136, 171-179.
7. Berners-Price, S.J., and P.W. Kuchel (1990). Reaction of cis- and trans-[PtCl2(NH3)2] with reduced glutathione studied by 1H, 13C, 19Pt, and 15N-{1H}DEPT NMR. J. Inorg. Biochem. 38, 305-326.
8. Beutler, E. (1975). Reduced glutathione (GSH) In: Red Cell Metabolism. A Manual of Biochemical Methods (Ed. E. Beutler). Grune and Straton, New York.
9. Beutler, E. (1982) Catalase. In: Red Cell Metabolism. A Manual of Biochemical Methods (Ed. E. Beutler), 105-106. Grune and Straton, New York.
10. Brandao, R., Lara, F.S., Pagliosa, L.B., Soares, F.A., Rocha, J.B., Nogueira, C.W., and M. Farina (2005). Hemolytic effects of sodium selenite and mercuric chloride in human blood. Drug Chem. Toxol. 28, 397-407.
11. Burk, R.F., Foster, K.A., Greenfield, P.M., Kiker, K.W., and J.P. Hammon (1974). Binding of simultaneously administered inorganic selenium and mercury to a rat plasma protein. Proc. Soc. Exp. Med. 144, 782-5.
12. Drabkin, D. and H. Austin (1935). Spectrophotometric studies preparations from washed blood cells. J. Biol. Chem. 112, 51-55.
13. Durak, I., Ozbek, H., Karaayvaz, M., and H.S. Ozturk (2002). Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: effects of antioxidant supplementation on the cisplatin nephrotoxicity. Drug Chem. Toxicol. 25, 1-8.
14. Friesen, C., Fulda, S., and K.M. Debatin (1999). Cytotoxic drugs and the CD95 pathway. Leukemia 13, 1854-1858.
15. Glatzle, D., Vuilleumier, J. P., Weber, F., and K. Decker (1974). Glutathione reductase test with whole blood, a convinient procedure for the assessment of riboflavin status in humans. Experientia 30, 665-667.
16. Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wishnok, J.S., and S.R. Tannenbaum (1982). Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal. Biochem. 126, 131-138.
17. Habig, W. H., Pabst, M. J., and W. B. Jakobay (1974). Glutathione S-transferase. J. Biol. Chem. 249, 7130-7139.
18. Halliwell, B., and J.M.C. Gutteridge (1999). In: Free Radicals in Biology and Medicine, 188-276. Oxford: Oxford University Press.
19. Hissin, P.J., and R. Hilf (1976). A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74, 214-226.
20. Imai, T., Mihara, H., Kurihara, T., and N. Esaki (2009). Selenocysteine is selectively taken up by red blood cells. Biosci. Biotechnol. Biochem. 73, 2746-2748.
21. Maral, J., Puget, K. and A. M. Michelson (1977). Comparative study of superoxide dismutase, catalase and glutathione peroxidase levels in erythrocytes of different animals. BBRC 77, 1525-35.
22. Marklund, S. and G. Marklund (1974). Involvement of superoxide anion radical in the autooxidation of pyrogallol and convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-474.
23. Marković, S.D., Djačić, D.S., Cvetković, D.M., Obradović, A.D., Žižić, J.B., Ognjanović, B.I., and A.Š. Štajn (2010). Effects of acute in vivo cisplatin and selenium treatment on hematological and oxidative stress parameters in red blood cells of rats. Biol. Trace. Elem. Res. DOI 10.1007/s12011-010-8788-9.
24. Naziroglu, M., Karaoǧlu, A., and A.O. Aksoy (2004). Selenium and high dose vitamin E administration protects cisplatininduced oxidative damage to renal, liver and lens tissues in rats. Toxicology 195, 221-230.
25. Ognjanović, B.I., Marković, S.D., Pavlović, S.Z., Žikic, R.V., Štajn, A.Š., and Z.S. Saičić (2008). Effect of chronic cadmium exposure on antioxidant defense system in some tissues of rats: protective effect of selenium. Physiol. Res. 57, 403-411.
26. Ohkawa, H., Ohishi, N., and K. Yagi (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
27. Olas, B., Wachowicz, B., Majsterek, I., and J. Blasiak (2005). Resveratrol may reduce oxidative stress induced by platinum compounds in human plasma, blood platelets and lymphocytes. Anticancer Drugs 16, 659-665.
28. Osanto, S., Thijssen, J.C.P., Woldering, V.M, Van Rijn, J.L.S., Natarajan, A.T., Tates, A.D., and A.V. Carrano (1991). Increased frequency of chromosomal damage in peripheral blood lymphocytes up to nine years following curative chemotherapy of patients with testicular carcinoma. Environ. Mol. Mutagen. 17, 71-8.
29. Perez, R.P. (1998). Cellular and molecular determinants of cisplatin resistance. Eur. J. Cancer 34, 1535-1542.
30. Philipps, K.A. and I.F. Tannock (1998). Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy. J. Clin. Oncol. 16, 3179-3190.
31. Pick, E. and Y. Keisari (1980). A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J. Immunol. Meth. 38, 161-170.
32. Rosenberg, B. (1985). Fundamental studies with cisplatin. Cancer 55, 2303-2315.
33. Santos, N.A.G., Catao Bezerra, C.S., Martins, N.M., Curti, C., Bianchi, M.L., and A.C. Santos (2008). Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Cancer Chemother. Pharmacol. 61, 145-155.
34. Schrauzer, G.N. (2009). Selenium and selenium-antagonistic elements in nutritional cancer prevention. Crit. Rev. Biotechnol. 29, 10-17.
35. Srivastava, R., Farookh, A., Ahmad, N., Misra, M., Hasan, S., and M. Husain (1996). Evidence for involvement of nitric oxide in cisplatin induced toxicity in rats. Biometals 9, 139-142.
36. Sugawara, N. and C. Sugawara (1987). Effect of oral selenium on cadmium absorption from the gastrointestinal tract. Trace Subst. Environ. Health 21, 440-449.
37. Suzuki, KT. and Y. Ogra (2002). Metabolic pathway for selenium in the body: speciation by HPLC-ICP MS with enriched Se. Food Addit. Contam. 19, 974-983.
38. Taguchi, T., Nazneen, A., Abid, M.R., and M.S. Razzaque (2005). Cisplatin-associated nephrotoxicity and pathological events. Contrib. Nephrol. 148, 107-121.
39. Tsuchihashi, M. (1923). Zur Kernntnis der Blutkatalase. Biochem. Z. 140, 65-74.
40. Von Hoff, D.D., Schilsky, R., and C.M. Richert (1979). Toxic effects of cis-dichlorodiammine platinum (II) in man. Cancer Treat. Rep. 63, 1527-1531.
41. Weijl, N.I., Cleton, F.J., and S. Osanto (1997). Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat. Rev. 23, 209-240.
42. Wink, D.A. and J.B. Mitchell (1998). Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25, 434-456.
43. Wood, P.A. and W.J.M. Hrusheeky (1995). Cisplatin-associated anemia: an erythropoietin deficiency syndrome. J. Clin. Invest. 95, 1650-1659.
44. Yoshida, M., Itzuka, K., Hara, M., Nishijima, H., Shimada, A., Nakada, K., Satoh, Y., Akama, Y., and A. Terada (2000). Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats. Tohoku J. Exp. Med. 191, 209-220.